UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000031823 |
|---|---|
| Receipt number | R000036346 |
| Scientific Title | A phase II trial evaluating the effect of olanzapine 5mg for breakthrough nausea and vomiting in patients receiving carboplatin based chemotherapy |
| Date of disclosure of the study information | 2018/03/21 |
| Last modified on | 2019/03/29 23:43:12 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/03/21 01:16:16 | ||
| 2 | Update | 2018/04/11 09:37:33 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2018/09/22 22:10:19 | Email1 |
|
| 4 | Update | 2018/09/22 22:11:12 | Email1 |
|
| 5 | Update | 2019/03/22 23:34:31 | Date of IRB Last follow-up date Date analysis concluded |
|
| 6 | Update | 2019/03/22 23:37:30 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Organization Organization Address Address Tel |
|
| 7 | Update | 2019/03/29 23:42:10 | Recruitment status |
|
| 8 | Update | 2019/03/29 23:43:12 | Number of participants that the trial has enrolled |
